<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36703736</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine.</ArticleTitle><Pagination><StartPage>1054312</StartPage><MedlinePgn>1054312</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1054312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2022.1054312</ELocationID><Abstract><AbstractText>The severe acute respiratory syndrome coronavirus - 2 (SARS - CoV - 2) was reported to cause the Wuhan outbreak of the corona virus disease 2019(COVID-19). To date, the COVID-19 has infected more than 600 million people gloabally. As a growing number of patients recover from acute infections and are discharged from hospitals, the proportion of patients in the recovery period is gradually increasing. Many of these individuals have been reported to experience multiple symptoms during the convalescence, such as fatigue, dyspnea and pain which are designated as "long-COVID", "post-COVID syndrome" or "recovery sequelae. We searched for recent articles published in PubMed on COVID-19 convalescence and found that the pathogenesis of COVID-19 convalescence is not yet well recognized. It may be associated with incomplete recovery of immune system, parenchymal organ damage (liver or lung), coagulation abnormalities, "second hit" caused by viral infection, and Phenomenon of Cell Senescence-Associated Secretory Phenotype (SASP). Some drugs and psychological factors of patients also play a non-negligible role in it. We also found that the effect of traditional Chinese medicine (TCM) is effective in the treatment of the COVID-19 recovery phase, which can not only relieve the corresponding symptoms, but also improve the indicators and pulmonary fibrosis. Bufei Huoxue Capsule, as the only drug explicitly mentioned for COVID-19 recovery period, can exert strong rehabilitative effects on physiological activity in patients recovering from COVID-19. In addition, in previous studies, traditional Chinese medicine has been confirmed to have the ability to resist cytokine storms, as well as improve coagulation and myocardial damage, which makes it have potential therapeutic advantages in targeting the hyperimmune response, coagulation abnormalities and myocardial damage existing in the recovery period. In conclusion, the clinical symptoms of patients convalescing from COVID-19 are complex, and its pathogenesis has not been elucidated. traditional Chinese medicine, as a traditional treatment, its specific action and mechanism need to be confirmed by more studies, so that it can play a better role.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Jiang, An, Duan, Lian, Jin, Zhang, Yang, Zhang, Kang and Sun.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Linlin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Xuedong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lian</LastName><ForeName>Fengmei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>De</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuehong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Cunqing</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">TCM (trad. Chinese medicine)</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">mechanism</Keyword><Keyword MajorTopicYN="N">recovery period</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>2</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36703736</ArticleId><ArticleId IdType="pmc">PMC9872123</ArticleId><ArticleId IdType="doi">10.3389/fphar.2022.1054312</ArticleId><ArticleId IdType="pii">1054312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmad J., Barnhart H. X., Bonacini M., Ghabril M., Hayashi P. H., Odin J. A., et al. (2022). Value of liver biopsy in the diagnosis of drug-induced liver injury. J. Hepatol. 76, 1070&#x2013;1078. 10.1016/j.jhep.2021.12.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.12.043</ArticleId><ArticleId IdType="pmc">PMC9018618</ArticleId><ArticleId IdType="pubmed">35074471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali L., Naeem M., Canibano B., John A., Iqrar A. (2021). Bilateral acute optic perineuritis associated with COVID-19 in a patient with seronegative myelin oligodendrocyte glycoprotein (MOG) antibody. Cureus 13, e18234. 10.7759/cureus.18234</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18234</ArticleId><ArticleId IdType="pmc">PMC8542256</ArticleId><ArticleId IdType="pubmed">34712522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali N. (2020). Relationship between COVID-19 infection and liver injury: A review of recent data. Front. Med. (Lausanne) 7, 458. 10.3389/fmed.2020.00458</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00458</ArticleId><ArticleId IdType="pmc">PMC7385135</ArticleId><ArticleId IdType="pubmed">32793619</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez A., Amirianfar E., Mason M. C., Huang L., Jose J., Tiu T. (2021). Extended neuralgic amyotrophy syndrome in a confirmed COVID-19 patient after intensive care unit and inpatient rehabilitation stay. Am. J. Phys. Med. Rehabil. 100, 733&#x2013;736. 10.1097/PHM.0000000000001795</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001795</ArticleId><ArticleId IdType="pubmed">34001839</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan N. A. (2021). The road to addressing Long Covid. Science 373, 491&#x2013;493. 10.1126/science.abg7113</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>An X., Duan L., Zhang Y. H., Jin D., Zhao S., Zhou R. R., et al. (2021a). The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin. Med. 16, 44. 10.1186/s13020-021-00454-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-021-00454-x</ArticleId><ArticleId IdType="pmc">PMC8182732</ArticleId><ArticleId IdType="pubmed">34099015</ArticleId></ArticleIdList></Reference><Reference><Citation>An Y. W., Yuan B., Wang J. C., Wang C., Liu T. T., Song S., et al. (2021b). Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19. Int. J. Med. Sci. 18, 646&#x2013;651. 10.7150/ijms.52664</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.52664</ArticleId><ArticleId IdType="pmc">PMC7797555</ArticleId><ArticleId IdType="pubmed">33437199</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir E., Aydemir G. A., Atesoglu H. I., Goker Y. S., Ozcelik K. C., Kiziltoprak H. (2021). The impact of coronavirus disease 2019 (COVID-19) on retinal microcirculation in human subjects. Klin. Monbl Augenheilkd 238, 1305&#x2013;1311. 10.1055/a-1579-0805</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1579-0805</ArticleId><ArticleId IdType="pubmed">34587629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian Y. Q., Ma J., Ren Y., Zhang Y. L., Qiao Y. J. (2020). Discovery of intervention effect of Chinese herbal formulas on COVID-19 pulmonary fibrosis treated by VEGFR and FGFR inhibitors. Zhongguo Zhong Yao Za Zhi 45, 1481&#x2013;1487. 10.19540/j.cnki.cjcmm.20200315.401</Citation><ArticleIdList><ArticleId IdType="doi">10.19540/j.cnki.cjcmm.20200315.401</ArticleId><ArticleId IdType="pubmed">32489024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Huang D., Yu H., Zhu Z., Xia Z., Su Y., et al. (2020). COVID-19: Abnormal liver function tests. J. Hepatol. 73, 566&#x2013;574. 10.1016/j.jhep.2020.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7194951</ArticleId><ArticleId IdType="pubmed">32298767</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso E. R., Bains S. S., Robison B., Farkas J. (2021). Superficial cerebral venous thrombosis and intracerebral hematoma in a 48-year-old man with SARS-CoV-2 infection: A case report. Am. J. Case Rep. 22, e927011. 10.12659/AJCR.927011</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.927011</ArticleId><ArticleId IdType="pmc">PMC7784591</ArticleId><ArticleId IdType="pubmed">33384403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K. H., Lim S. L., Shaaban H., Guron G., Slim J. (2021). Persistent hypercoagulable state in COVID-19: A case series of COVID-19 associated pulmonary embolism. J. Glob. Infect. Dis. 13, 38&#x2013;41. 10.4103/jgid.jgid_180_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jgid.jgid_180_20</ArticleId><ArticleId IdType="pmc">PMC8054785</ArticleId><ArticleId IdType="pubmed">33911452</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu C., Wang T., Qi J., Jia X., Zeng X., et al. (2022). Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial. J. Ethnopharmacol. 284, 114830. 10.1016/j.jep.2021.114830</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.114830</ArticleId><ArticleId IdType="pmc">PMC8575540</ArticleId><ArticleId IdType="pubmed">34763045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z. (2021). Therapeutic effect of cultivating Earth and generating gold on novel coronavirus pneumonia in convalescent stage. Med. Diet Health 19 (16), 2334.</Citation></Reference><Reference><Citation>Chew M., Tang Z., Radcliffe C., Caruana D., Doilicho N., Ciarleglio M. M., et al. (2021). Significant liver injury during hospitalization for COVID-19 is not associated with liver insufficiency or death. Clin. Gastroenterol. Hepatol. 19, 2182&#x2013;2191.e7. 10.1016/j.cgh.2021.05.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2021.05.022</ArticleId><ArticleId IdType="pmc">PMC8123528</ArticleId><ArticleId IdType="pubmed">34004326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh F. W., Fong S. W., Young B. E., Wu K. X., Siau A., Krishnan S., et al. (2021). Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife 10, e64909. 10.7554/eLife.64909</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Chorin E., Wadhwani L., Magnani S., Dai M., Shulman E., Nadeau-Routhier C., et al. (2020). QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart rhythm. 17, 1425&#x2013;1433. 10.1016/j.hrthm.2020.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.05.014</ArticleId><ArticleId IdType="pmc">PMC7214283</ArticleId><ArticleId IdType="pubmed">32407884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;S-Telles A., L&#xf3;PEZ-Romero S., Figueroa-Hurtado E., Pou-Aguilar Y. N., Wong A. W., Milne K. M., et al. (2021). Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir. Physiol. Neurobiol. 288, 103644. 10.1016/j.resp.2021.103644</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19 Drugs (2012). LiverTox: Clinical and research information on drug-induced liver injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases.</Citation><ArticleIdList><ArticleId IdType="pubmed">31643176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y., Qiang W., Gui Y., Tan X., Pei T., Lin K., et al. (2021). A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines. Sci. Bull. (Beijing) 66, 884&#x2013;888. 10.1016/j.scib.2021.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7803147</ArticleId><ArticleId IdType="pubmed">33457042</ArticleId></ArticleIdList></Reference><Reference><Citation>Damodaran S., Joshi S. S., Kumar V. S., Natarajan P., Patangi S. O., Kumaran T. (2021). COVID convalescence-A boon or bane in cardiac surgery?: A "second hit" hypothesis. J. Cardiothorac. Vasc. Anesth. 35, 3315&#x2013;3318. 10. 10.1053/j.jvca.2020.10.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.10.021</ArticleId><ArticleId IdType="pmc">PMC7568463</ArticleId><ArticleId IdType="pubmed">33158710</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S. E., Guo Y., Heath K., Dasmari&#xf1;AS M. C., Jubilo K. G., Samranvedhya J., et al. (2021). Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. Bmj 373, n1098. 10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Delbressine J. M., Machado F. V. C., Go&#xeb;RTZ Y. M. J., Van Herck M., Meys R., Houben-Wilke S., et al. (2021). The impact of post-COVID-19 syndrome on self-reported physical activity. Int. J. Environ. Res. Public Health 18, 6017. 10.3390/ijerph18116017</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18116017</ArticleId><ArticleId IdType="pmc">PMC8199934</ArticleId><ArticleId IdType="pubmed">34205086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Z. Y., Li G. X., Chen L., Shu C., Song J., Wang W., et al. (2021). Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J. Hepatol. 74, 1295&#x2013;1302. 10.1016/j.jhep.2020.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.12.012</ArticleId><ArticleId IdType="pmc">PMC7749734</ArticleId><ArticleId IdType="pubmed">33347952</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmunzer B. J., Spitzer R. L., Foster L. D., Merchant A. A., Howard E. F., Patel V. A., et al. (2021). Digestive manifestations in patients hospitalized with coronavirus disease 2019. Clin. Gastroenterol. Hepatol. 19, 1355&#x2013;1365.e4. e410. 10.1016/j.cgh.2020.09.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.09.041</ArticleId><ArticleId IdType="pmc">PMC7527302</ArticleId><ArticleId IdType="pubmed">33010411</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Zhou J., Ding X., Ling G., Yu S. (2020). Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience. Am. J. Emerg. Med. 38, 2134&#x2013;2138. 10.1016/j.ajem.2020.05.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.05.120</ArticleId><ArticleId IdType="pmc">PMC7368908</ArticleId><ArticleId IdType="pubmed">33071084</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Ward S. E., Townsend L., Karampini E., Elliott S., Conlon N., et al. (2022). Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J. Thromb. Haemost. 20, 2429&#x2013;2438. 10.1111/jth.15830</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan Q., Gong B., Sun M., Cao Z., Zheng Y., Zhang Y., et al. (2021). A high percentage of patients recovered from COVID-19 but discharged with abnormal liver function tests. Front. Physiol. 12, 642922. 10.3389/fphys.2021.642922</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.642922</ArticleId><ArticleId IdType="pmc">PMC8015938</ArticleId><ArticleId IdType="pubmed">33815147</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng H., Xie Y. (2021). Discussion on the mechanism of immune function regulation of traditional Chinese medicine in convalescent and discharged patients with new coronavirus pneumonia. Mod. Traditional Chin. Med. Materia Medica-World Sci. Technol. 23 (02), 482&#x2013;487. 10.11842/wst.20200405012</Citation><ArticleIdList><ArticleId IdType="doi">10.11842/wst.20200405012</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidary A. M., Noor S., Hamed E., Baryali T., Rahmani S., Ahmad M., et al. (2021). Acute motor-sensory axonal polyneuropathy variant of guillain-barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: A case report. J. Med. Case Rep. 15, 379. 10.1186/s13256-021-02988-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-021-02988-y</ArticleId><ArticleId IdType="pmc">PMC8283095</ArticleId><ArticleId IdType="pubmed">34271989</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H., Van Der Hoeven J. G., Corsten S., Janssen I., Ewalds E., Simons K. S., et al. (2022). Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. Jama. DOI 327, 559&#x2013;565. 10.1001/jama.2022.0040</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.0040</ArticleId><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H., Zhang Y., Tang G., Luo Y., Liu W., Cheng C., et al. (2021). Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection. J. Allergy Clin. Immunol. 148, 1481&#x2013;1492.e2. e2. 10.1016/j.jaci.2021.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.09.008</ArticleId><ArticleId IdType="pmc">PMC8440318</ArticleId><ArticleId IdType="pubmed">34536418</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K., Zhang P., Zhang Z., Youn J. Y., Wang C., Zhang H., et al. (2021). Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms. Pharmacol. Ther. 225, 107843. 10.1016/j.pharmthera.2021.107843</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107843</ArticleId><ArticleId IdType="pmc">PMC8011334</ArticleId><ArticleId IdType="pubmed">33811957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hundt M. A., Deng Y., Ciarleglio M. M., Nathanson M. H., Lim J. K. (2020). Abnormal liver tests in COVID-19: A retrospective observational cohort study of 1, 827 patients in a major U.S. Hospital network. Hepatology 72, 1169&#x2013;1176. 10.1002/hep.31487</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31487</ArticleId><ArticleId IdType="pmc">PMC9258788</ArticleId><ArticleId IdType="pubmed">32725890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ide S., Hayama H., Asai Y., Terada M., Nomoto H., Kutsuna S., et al. (2021). Evaluation of high-sensitivity cardiac troponin T levels in Japanese patients recently recovered from coronavirus disease 2019. Circ. J. 85, 944&#x2013;947. 10.1253/circj.CJ-21-0219</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-21-0219</ArticleId><ArticleId IdType="pubmed">33994409</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W. M., Boas S. J., Dickerman A. L. (2021). Behavioral interventions in acute COVID-19 recovery: A new opportunity for integrated care. Gen. Hosp. Psychiatry 69, 113&#x2013;114. 10.1016/j.genhosppsych.2020.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2020.07.001</ArticleId><ArticleId IdType="pmc">PMC7340026</ArticleId><ArticleId IdType="pubmed">32654787</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin D., An X., Zhang Y., Zhao S., Duan L., Duan Y., et al. (2021). Potential mechanism prediction of herbal medicine for pulmonary fibrosis associated with SARS-CoV-2 infection based on network analysis and molecular docking. Front. Pharmacol. 12, 602218. 10.3389/fphar.2021.602218</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.602218</ArticleId><ArticleId IdType="pmc">PMC8112227</ArticleId><ArticleId IdType="pubmed">33986661</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalimuddin S., Teh Y. E., Wee L. E., Paintal S., Sasisekharan R., Low J. G., et al. (2022). Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illness. PLoS Negl. Trop. Dis. 16, e0010724. 10.1371/journal.pntd.0010724</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0010724</ArticleId><ArticleId IdType="pmc">PMC9426910</ArticleId><ArticleId IdType="pubmed">35981059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp H. I., Corner E., Colvin L. A. (2020). Chronic pain after COVID-19: Implications for rehabilitation. Br. J. Anaesth. 125, 436&#x2013;440. 10.1016/j.bja.2020.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.021</ArticleId><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J. S., Lee J. Y., Yang J. W., Lee K. H., Effenberger M., Szpirt W., et al. (2021). Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics 11, 316&#x2013;329. 10.7150/thno.49713</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.49713</ArticleId><ArticleId IdType="pmc">PMC7681075</ArticleId><ArticleId IdType="pubmed">33391477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirshblum S. C., Delauter G., Eren F., Pomeranz B., Deluca R., Hammerman S., et al. (2021). Screening for deep vein thrombosis in persons with COVID-19 upon admission to an inpatient rehabilitation hospital. Am. J. Phys. Med. Rehabil. 100, 419&#x2013;423. 10.1097/PHM.0000000000001729</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001729</ArticleId><ArticleId IdType="pubmed">33819922</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight D. S., Kotecha T., Razvi Y., Chacko L., Brown J. T., Jeetley P. S., et al. (2020). COVID-19: Myocardial injury in survivors. Circulation 142, 1120&#x2013;1122. 10.1161/CIRCULATIONAHA.120.049252</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049252</ArticleId><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehn B. M. (2021). Post-COVID-19 symptoms were worse than cancer's effects. Jama 326, 692. 10.1001/jama.2021.12353</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.12353</ArticleId><ArticleId IdType="pubmed">34427593</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Gou C. Y., Li X. M., Song W. Y., Wang X. J., Li H. Y., et al. (2021a). Effects of Chinese medicine on symptoms, syndrome evolution, and lung inflammation absorption in COVID-19 convalescent patients during 84-day follow-up after hospital discharge: A prospective cohort and nested case-control study. Chin. J. Integr. Med. 27, 245&#x2013;251. 10.1007/s11655-021-3328-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-021-3328-3</ArticleId><ArticleId IdType="pmc">PMC7857094</ArticleId><ArticleId IdType="pubmed">33534076</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li B., Wang P., Wang Q. (2021b). Traditional Chinese medicine, Qingfei paidu decoction and xuanfei baidu decoction, inhibited cytokine production via NF-&#x3ba;B signaling pathway in macrophages: Implications for coronavirus disease 2019 (COVID-19) therapy. Front. Pharmacol. 12, 722126. 10.3389/fphar.2021.722126</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.722126</ArticleId><ArticleId IdType="pmc">PMC8576273</ArticleId><ArticleId IdType="pubmed">34764867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T., Li L., Liang C., Zeng H., Li X., Peng L. (2020). "Discussion on network pharmacology of shenling baizhu powder in the treatment of COVID-19 in recovery Phase"Evaluation and analysis of drug-use in hospitals of China 20(12): 1433&#x2013;1436+1441. 10.14009/j.issn.1672-2124.2020.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.14009/j.issn.1672-2124.2020.12.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B. M., Yang Q. Q., Zhao L. Y., Xie W., Si X. Y. (2020). Epidemiological characteristics of COVID-19 patients in convalescence period. Epidemiol. Infect. 148, e108. 10.1017/s0950268820001181</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0950268820001181</ArticleId><ArticleId IdType="pmc">PMC7287303</ArticleId><ArticleId IdType="pubmed">32487271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H., Wang Y., Tan C., Qian F., Jiang X., Dai G., et al. (2020). Medication analysis of forty cured patients with novel coronavirus pneumonia. Chin. J. Drug Appl. Monit. 17 (03), 191&#x2013;194. 10.3969/j.issn.1672-8157.2020.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1672-8157.2020.03.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Masi&#xe1; M., Fern&#xe1;NDEZ-Gonz&#xe1;LEZ M., Telenti G., Agull&#xf3; V., Garc&#xed;A J. A., Padilla S., et al. (2021). Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study. J. Autoimmun. 123, 102703. 10.1016/j.jaut.2021.102703</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102703</ArticleId><ArticleId IdType="pmc">PMC8289631</ArticleId><ArticleId IdType="pubmed">34303083</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., et al. (2022). Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 182, 19&#x2013;25. 10.1001/jamainternmed.2021.6454</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Medetalibeyoglu A., Catma Y., Senkal N., Ormeci A., Cavus B., Kose M., et al. (2020). The effect of liver test abnormalities on the prognosis of COVID-19. Ann. Hepatol. 19, 614&#x2013;621. 10.1016/j.aohep.2020.08.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aohep.2020.08.068</ArticleId><ArticleId IdType="pmc">PMC7481800</ArticleId><ArticleId IdType="pubmed">32920162</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa M., Nakajima M., Kaszynski R. H., Hamada S., Nakano T., Shirokawa M., et al. (2021). Two cases of post-intubation laryngotracheal stenosis occurring after severe COVID-19. Intern Med. 60, 473&#x2013;477. 10.2169/internalmedicine.6105-20</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.6105-20</ArticleId><ArticleId IdType="pmc">PMC7925275</ArticleId><ArticleId IdType="pubmed">33328406</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretta P., Maniscalco M., Papa A., Lanzillo A., Trojano L., Ambrosino P. (2022). Cognitive impairment and endothelial dysfunction in convalescent COVID-19 patients undergoing rehabilitation. Eur. J. Clin. Invest. 52, e13726. 10.1111/eci.13726</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13726</ArticleId><ArticleId IdType="pubmed">34921559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunna K., Braun A. B. (2021). Development of a large spontaneous pneumothorax after recovery from mild COVID-19 infection. BMJ Case Rep. 14, e238863. 10.1136/bcr-2020-238863</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-238863</ArticleId><ArticleId IdType="pmc">PMC7813402</ArticleId><ArticleId IdType="pubmed">33462033</ArticleId></ArticleIdList></Reference><Reference><Citation>Parums D. V. (2021). Editorial: Long COVID, or post-COVID syndrome, and the global impact on health care. Med. Sci. Monit. 27, e933446. 10.12659/MSM.933446</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933446</ArticleId><ArticleId IdType="pmc">PMC8194290</ArticleId><ArticleId IdType="pubmed">34092779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponziani F. R., Del Zompo F., Nesci A., Santopaolo F., Ianiro G., Pompili M., et al. (2020). Liver involvement is not associated with mortality: Results from a large cohort of SARS-CoV-2-positive patients. Aliment. Pharmacol. Ther. 52, 1060&#x2013;1068. 10.1111/apt.15996</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15996</ArticleId><ArticleId IdType="pmc">PMC7361563</ArticleId><ArticleId IdType="pubmed">32628793</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Amara V., Chaudhuri S., Rao B. K., Todur P. (2021). Post-COVID-19 syndrome:" the new pandemic affecting healthcare workers and how the frontline warriors are battling it. Indian J. Palliat. Care 27, 313&#x2013;318. 10.25259/IJPC_160_21</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/IJPC_160_21</ArticleId><ArticleId IdType="pmc">PMC8428886</ArticleId><ArticleId IdType="pubmed">34511802</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Morales M. D., Pell R., Rubero J., Ganti L. (2020). Acute myopericarditis in the post COVID-19 recovery phase. Cureus 12, e11247. 10.7759/cureus.11247</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11247</ArticleId><ArticleId IdType="pmc">PMC7707144</ArticleId><ArticleId IdType="pubmed">33274129</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts L. N., Whyte M. B., Georgiou L., Giron G., Czuprynska J., Rea C., et al. (2020). Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood 136, 1347&#x2013;1350. 10.1182/blood.2020008086</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008086</ArticleId><ArticleId IdType="pmc">PMC7483432</ArticleId><ArticleId IdType="pubmed">32746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeki T., Ogawa F., Matsumiya M., Yamamura M., Oritsu H., Nonogaki M., et al. (2021). Long-term decreased exercise capacity of COVID-19 patients who received mechanical ventilation in Japan: A case series. Am. J. Phys. Med. Rehabil. 100, 737&#x2013;741. 10.1097/PHM.0000000000001803</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001803</ArticleId><ArticleId IdType="pubmed">34091469</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman D., Vishnubala D., Le Feuvre P., Beaney T., Korgaonkar J., Majeed A., et al. (2021). Returning to physical activity after Covid-19. Bmj 372, m4721. 10.1136/bmj.m4721</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4721</ArticleId><ArticleId IdType="pubmed">33419740</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana M. F., Guerra M. T., Hundt M. A., Ciarleglio M. M., Pinto R. A. A., Dutra B. G., et al. (2022). Correlation between clinical and pathological findings of liver injury in 27 patients with lethal COVID-19 infections in Brazil. Hepatol. Commun. 6, 270&#x2013;280. 10.1002/hep4.1820</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep4.1820</ArticleId><ArticleId IdType="pmc">PMC8652714</ArticleId><ArticleId IdType="pubmed">34520633</ArticleId></ArticleIdList></Reference><Reference><Citation>Satapathy S. K., Kuntzen C., Qiu H., Jiang Y., Bodenheimer H. C., Roth N. C., et al. (2021). Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality. Eur. J. Gastroenterol. Hepatol. 33, e320&#x2013;e328. 10.1097/MEG.0000000000002055</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000002055</ArticleId><ArticleId IdType="pmc">PMC8734572</ArticleId><ArticleId IdType="pubmed">33560687</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Ba Y., Hu Y., Wang L., Li W., Yuan J. (2021). Analysis of relationship between dynamic changes of serum SARS-CoV-2 specific lgM/lgG and patient immunity in recovery stage. Acta Med. Univ. Sci. Technol. Huazhong 50 (03), 366&#x2013;369. 10.3870/j.issn.1672-0741.2021.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.3870/j.issn.1672-0741.2021.03.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Fang Z., Xiong K., Ye D., Wang W., Chen Y., et al. (2020). Clinical observation of the rehabilitation formula for banking up earth to generate metal in treatin COVID-19 patients with deficiency of lung and spleen syndrome in the recovery stage. J. Nanjing Univ. Traditional Chin. Med. 36 (03), 281&#x2013;285. 10.14148/j.issn.1672-0482.2020.0281</Citation><ArticleIdList><ArticleId IdType="doi">10.14148/j.issn.1672-0482.2020.0281</ArticleId></ArticleIdList></Reference><Reference><Citation>Sklinda K., Dorobek M., Wasilewski P. G., Dre&#x17c;ewski K., D&#x229;bicka M., Walecki J., et al. (2021). Radiological manifestation of neurological complications in the course of SARS-CoV-2 infection. Front. Neurol. 12, 711026. 10.3389/fneur.2021.711026</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.711026</ArticleId><ArticleId IdType="pmc">PMC8563625</ArticleId><ArticleId IdType="pubmed">34744963</ArticleId></ArticleIdList></Reference><Reference><Citation>Teschke R., M&#xe9;NDEZ-S&#xe1;NCHEZ N., Eickhoff A. (2022). Liver injury in COVID-19 patients with drugs as causatives: A systematic review of 996 DILI cases published 2020/2021 based on RUCAM as causality assessment method. Int. J. Mol. Sci. 23, 4828. 10.3390/ijms23094828</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094828</ArticleId><ArticleId IdType="pmc">PMC9100611</ArticleId><ArticleId IdType="pubmed">35563242</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Official Product Information for Bufei Huoxue Capsule (2022). Available at: http://www.lys.cn/productsandintroductions/info.aspx?itemid=55&amp;Lcid=20 (Accessed December 15, 2022).</Citation></Reference><Reference><Citation>Trinkmann F., M&#xfc;LLER M., Reif A., Kahn N., Kreuter M., Trudzinski F., et al. (2021). Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. Eur. Respir. J. 57, 2003002. 10.1183/13993003.03002-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03002-2020</ArticleId><ArticleId IdType="pmc">PMC7821834</ArticleId><ArticleId IdType="pubmed">33479105</ArticleId></ArticleIdList></Reference><Reference><Citation>Truffaut L., Demey L., Bruyneel A. V., Roman A., Alard S., De Vos N., et al. (2021). Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir. Res. 22, 29. 10.1186/s12931-021-01625-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01625-y</ArticleId><ArticleId IdType="pmc">PMC7819622</ArticleId><ArticleId IdType="pubmed">33478527</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsch&#xf6;PE C., Sherif M., Anker M. S., Geisel D., Kuehne T., Kelle S. (2021). COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture. Esc. Heart Fail 8, 971&#x2013;973. 10.1002/ehf2.13186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13186</ArticleId><ArticleId IdType="pmc">PMC8006695</ArticleId><ArticleId IdType="pubmed">33410259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S., Minami S., Hashimoto R., Konishi Y., Suzuki T., Kondo T., et al. (2022). SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nat. Aging. DOI 2, 115&#x2013;124. 10.1038/s43587-022-00170-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00170-7</ArticleId><ArticleId IdType="pmc">PMC10154207</ArticleId><ArticleId IdType="pubmed">37117754</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzunova G., Pallanti S., Hollander E. (2021). Presentation and management of anxiety in individuals with acute symptomatic or asymptomatic COVID-19 infection, and in the post-COVID-19 recovery phase. Int. J. Psychiatry Clin. Pract. 25, 115&#x2013;131. 10.1080/13651501.2021.1887264</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651501.2021.1887264</ArticleId><ArticleId IdType="pubmed">33635172</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Shi S., Zhang X. (2021). Exploration on mechanism of futu shengjin rehabilitation formula in regulating immune function during COVID-19 convalescence based on the network pharmacology. J. Nanjing Univ. Traditional Chin. Med. 37 (01), 91&#x2013;95. 10.14148/j.issn.1672-0482.2021.0091</Citation><ArticleIdList><ArticleId IdType="doi">10.14148/j.issn.1672-0482.2021.0091</ArticleId></ArticleIdList></Reference><Reference><Citation>
Who (2022). E. WHO coronavirus(COVID-19) Pandemic
. https://covid19.who.int/(Accessed November 28, 2022).</Citation></Reference><Reference><Citation>Wong S. W., Fan B. E., Huang W., Chia Y. W. (2021). ST-segment elevation myocardial infarction in post-COVID-19 patients: A case series. Ann. Acad. Med. Singap 50, 425&#x2013;430. 10.47102/annals-acadmedsg.202175</Citation><ArticleIdList><ArticleId IdType="doi">10.47102/annals-acadmedsg.202175</ArticleId><ArticleId IdType="pubmed">34100519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Zhong L., Li H., Guo J., Li Y., Hou X., et al. (2021). A follow-up study of lung function and chest computed tomography at 6 Months after discharge in patients with coronavirus disease 2019. Can. Respir. J. 2021, 6692409. 10.1155/2021/6692409</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6692409</ArticleId><ArticleId IdType="pmc">PMC7881736</ArticleId><ArticleId IdType="pubmed">33628349</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., et al. (2021). Clinical sequelae of COVID-19 survivors in wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 27, 89&#x2013;95. 10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L. L., Zhang W. Y., Wei X. H., Yan L., Pan C. S., Yu Y., et al. (2018). Gualou xiebai decoction, a traditional Chinese medicine, prevents cardiac reperfusion injury of hyperlipidemia rat via energy modulation. Front. Physiol. 9, 296. 10.3389/fphys.2018.00296</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00296</ArticleId><ArticleId IdType="pmc">PMC5895855</ArticleId><ArticleId IdType="pubmed">29674972</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Lin R., Dong X., Guo G., Zhang B., Li Y., et al. (2021). Xiang huo spray combined with basic rehabilitation therapy in treating 60 cases of COVID- 19 with syndrome of residual toxin during convalescence period. J. Traditional Chin. Med. 62 (17), 1509&#x2013;1513. 10.13288/j.11-2166/r.2021.17.009</Citation><ArticleIdList><ArticleId IdType="doi">10.13288/j.11-2166/r.2021.17.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Liu S., Liu J., Zhang Z., Wan X., Huang B., et al. (2020a). COVID-19: Immunopathogenesis and immunotherapeutics. Signal Transduct. Target Ther. 5, 128. 10.1038/s41392-020-00243-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00243-2</ArticleId><ArticleId IdType="pmc">PMC7381863</ArticleId><ArticleId IdType="pubmed">32712629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z. L., Chen C., Huang L., Zhou S. C., Hu Y. N., Xia L. M., et al. (2020b). Fibrotic changes depicted by thin-section CT in patients with COVID-19 at the early recovery stage: Preliminary experience. Front. Med. (Lausanne) 7, 605088. 10.3389/fmed.2020.605088</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.605088</ArticleId><ArticleId IdType="pmc">PMC7732534</ArticleId><ArticleId IdType="pubmed">33330571</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y., Yue Z., Ding Y., Yu S. (2021). Study on the mechanism of Buzhong Yiqi decoction on the recovery period of COVID-19 based on network pharmacology. J. Shandong Univ. Traditional Chin. Med. 45 (05), 685&#x2013;694. 10.16294/j.cnki.1007-659x.2021.05.022</Citation><ArticleIdList><ArticleId IdType="doi">10.16294/j.cnki.1007-659x.2021.05.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D., An G. Y. (2017). Clinical effects of xihuang pill combined with chemotherapy in patients with advanced colorectal cancer. Evid. Based Complement. Altern. Med. 2017, 5936086. 10.1155/2017/5936086</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/5936086</ArticleId><ArticleId IdType="pmc">PMC5387817</ArticleId><ArticleId IdType="pubmed">28458715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan B., Li W., Liu H., Cai X., Song S., Zhao J., et al. (2020). Correlation between immune response and self-reported depression during convalescence from COVID-19. Brain Behav. Immun. 88, 39&#x2013;43. 10.1016/j.bbi.2020.05.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.062</ArticleId><ArticleId IdType="pmc">PMC7247486</ArticleId><ArticleId IdType="pubmed">32464158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu L., Yang B., Li R., Luo J., Huang J., et al. (2020). Clinical characteristics of 134 convalescent patients with COVID-19 in Guizhou, China. Respir. Res. 21, 314. 10.1186/s12931-020-01580-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01580-0</ArticleId><ArticleId IdType="pmc">PMC7689638</ArticleId><ArticleId IdType="pubmed">33243228</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Yan X., Ma F., Xia Q., Lu Y., Li W., et al. (2021)., 100. Medicine (Baltimore), e25389. 10.1097/MD.0000000000025389 Effects of moxibustion for COVID-19 convalescence: A protocol for systematic review and meta-analysis Medicine</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000025389</ArticleId><ArticleId IdType="pmc">PMC8036045</ArticleId><ArticleId IdType="pubmed">33832128</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Zhang S., Qin Y., Feng J., Yang F., Zhang B. (2021). Review of the sequelae of the coronavirus disease 2019(COVID-19) and the rehabilitation strategy with integrative Chinese and western medicine. J. Traditional Chin. Med. 62 (24), 2198&#x2013;2203. 10.13288/j.11-2166/r.2021.24.015</Citation><ArticleIdList><ArticleId IdType="doi">10.13288/j.11-2166/r.2021.24.015</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>